The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed at $17.28 in the last session, down -0.58% from day before closing price of $17.38. In other words, the price has decreased by -$0.58 from its previous closing price. On the day, 0.87 million shares were traded. PHAT stock price reached its highest trading level at $17.75 during the session, while it also had its lowest trading level at $16.94.
Ratios:
We take a closer look at PHAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 15 ’24 when Nabulsi Azmi sold 10,901 shares for $11.72 per share. The transaction valued at 127,760 led to the insider holds 240,421 shares of the business.
Henderson Molly sold 4,325 shares of PHAT for $50,689 on Jul 15 ’24. The CFO and CBO now owns 99,447 shares after completing the transaction at $11.72 per share. On Jul 15 ’24, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 33,848 shares for $11.72 each. As a result, the insider received 396,699 and left with 377,734 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 1186187392 and an Enterprise Value of 1259922432. For the stock, the TTM Price-to-Sale (P/S) ratio is 118.96. Its current Enterprise Value per Revenue stands at 127.034 whereas that against EBITDA is -4.998.
Stock Price History:
Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $6.07. The 50-Day Moving Average of the stock is 3.45%, while the 200-Day Moving Average is calculated to be 48.43%.
Shares Statistics:
According to the various share statistics, PHAT traded on average about 971.81K shares per day over the past 3-months and 1065250 shares per day over the past 10 days. A total of 57.97M shares are outstanding, with a floating share count of 37.51M. Insiders hold about 45.07% of the company’s shares, while institutions hold 47.59% stake in the company. Shares short for PHAT as of 1728950400 were 17555904 with a Short Ratio of 18.07, compared to 1726185600 on 15517989. Therefore, it implies a Short% of Shares Outstanding of 17555904 and a Short% of Float of 36.3.
